NOTICE OF INTENT TO ISSUE A PURCHASE ORDER. The Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, hereby announces its intent to issue a purchase order to GenScript USA Inc., 120 Centennial Avenue, Piscataway, NJ 08854 for services of GenScript USA Inc. for the purpose of synthesizing specific DNA constructs and clones based on descriptions and specifications provided by laboratory personnel in PPLB/DVD/NCIRD. A contract was issued to Genscript for the services listed above based in a competitive procurement. At the time of the award, GenScript was the lowest bidder and determined the most advantageous for the Government. The constructs provided by GenScript have been validated and must be used for the follow-on effort to earlier work to ensure results are consistent across the entire project. Having already invested a year in this project, it would be time consuming and result in additional cost and unreasonable delay to validate additional products.

This project is supported by justification for other than full and open competition is to GenScript under authority of 41 U.S.C., 253(c)(1). Responsible sources that believe they possess the expertise and capabilities identified above are encouraged to submit to the Contracting Officer within 15 days from the posting of this notice, their written capabilities statement and pricing information in the format they choose, not to exceed 10 pages. Please forward the capability statement and pricing information to Maria Shamburger, Procurement and Grants Office, 2920 Brandywine Rd, Atlanta, GA 30341, Reference 2010-83092. All vendors must be registered in the Central Contractor Registry (CCR) prior to an award of a federal contract. The website is: www.ccr.gov. The Government will review any/all capabilities statements and pricing information submitted and determine if other qualified sources do exist that could provide this requirement. Information received in response to this announcement will be used solely for the purpose of determining whether to conduct a competitive procurement.

If no affirmative responses are received within 15 days, in accordance with FAR 13.406-1(b)(1), negotiations will be conducted with GenScript as the only source and a purchase order will be issued without any additional notices being posted. For contractual questions contact Maria Shamburger by email at [email protected].

 

 

Bid Protests Not Available